Clinical Trial Update: A Trial of SHR-1905 in Healthy Subjects and Subjects With Mild Asthma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for SHR-1905 in healthy subjects and individuals with mild asthma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SHR-1905

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Asthma | Phase 1 | Status: COMPLETED